You are here: Industry Insights > COVID-19

News List

EIB to support COVID-19 therapy with €24.5 million investment europeanpharmaceuticalreview
October 22, 2020
The European Investment Bank (EIB) will provide Immunic with up to €24.5 million to support the ongoing development of IMU-838, a potential COVID-19 therapy.
First Patient Dosed in Trial to Treat Complications in COVID-19 americanpharmaceuticalreview
October 22, 2020
Arch Biopartners has dosed the first patient in the Phase II trial of its lead drug LSALT peptide, targeting prevention of acute lung injury, acute kidney injury and other complications caused by inflammation in hospitalized patients with moderate to ...
Genalyte Obtains EUA for Rapid COVID-19 Antibody Test americanpharmaceuticalreview
October 22, 2020
Genalyte announced its SARS-CoV-2 Multi-Antigen Serology Panel has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
Symvivo to develop Covid-19 oral vaccine candidate with new funding pharmaceutical-technology
October 22, 2020
Symvivo will be receiving advisory services and funding of up to $2.8m to support the clinical advancement of a vaccine candidate to prevent Covid-19.
AstraZeneca, U.S. Govt. Enter $486M COVID-19 Antibody Agreement contractpharma
October 22, 2020
Funding will be used for two Phase III trials and related development and manufacturing activities for the supply of AZD7442 doses in the U.S.
UK and hVIVO to develop Covid-19 human study model pharmaceutical-technology
October 22, 2020
The UK Government has signed a contract with Open Orphan subsidiary hVIVO for the development of a Covid-19 human challenge study model.
India’s role in global supply of COVID-19 drugs and vaccines remains crucial despite IPR waiver decision: GlobalData expresspharma
October 22, 2020
Following the news that the US and EU have blocked India’s fight for intellectual property rights (IPR) waiver for COVID-19 drugs; Prashant Khadayate, Pharma Analyst at GlobalData, offers his view.
Researchers find corticosteroids combo is most effective for COVID-19 cytokine storm treatment expresspharma
October 22, 2020
Additionally, there was an improvement if corticosteroids were used alone, or in combination with tocilizumab or anakinra when compared with standard of care.
Bill & Melinda Gates Foundation and Grand Challenges Partners announce new initiatives to advance global health innovation expresspharma
October 22, 2020
Researchers and scientists from around the world convene to accelerate R&D to address COVID-19 and other global health challenges.
Samsung Biologics, Dinona Partner on Potential COVID-19 Antibody Therapy contractpharma
October 22, 2020
Will collaborate for fast-track development of DNP-019, a potential COVID-19 antibody therapy.